AIIMS Delhi Releases Guidelines For Covid-19 Suspected And Positive Cases

AIIMS Delhi Releases Guidelines For Covid-19 Suspected And Positive Cases

NewDelhi: All India Institute of Medical Sciences (AIIMS) Delhi on Wednesday released directives for individuals suspected or confirmed with Covid-19, to be observed at hospitals in response to the abrupt increase in Coronavirus cases across the nation.

Amid the surging coronavirus cases, the director of AIIMS Delhi convened a meeting with department heads of the hospital to discuss contingency measures for Covid-19 on Wednesday. The meeting focused on formulating policies for Covid-19 testing, identifying specific areas for positive patients, and outlining procedures for their hospitalization.

As per the policy on Covid-19 testing, directed by the management, testing will be done for patients with SARI (severe acute respiratory infection) like symptoms that include according to the WHO, acute respiratory infection, persistent fever or fever of >= 38 C° with cough and onset within last 10 days. The office memorandum was issued after the meeting.

It further asked all the departments at the institution to make provisions in their respective designated wards to manage in-patients who have tested positive for COVID-19.
“12 beds in the C6 ward will be earmarked for hospitalization of seriously ill Covid-19 patients,” the memorandum said.

It also said that a screening OPD in the Emergency Department will screen patients for Covid-like symptoms and triage them same based on the medical requirements.
“Rooms no 1 to 12 in the new private ward are to be earmarked for hospitalization of Covid-19 positive EHS beneficiaries,” it added.

“Engineering works in the New Blocks, Masjid Moth Campus–The ESD is required to install UVGA filters and HEPA filters in all the new blocks situated in the Masjid Moth Campus at the earliest,” it said further.

Notably, the national capital has reported the first case of JN.1 variant infection. “Delhi has reported the first case of JN.1, a Sub-Variant of Omicron. Out of the 3 samples sent for Genome Sequencing, one is JN.1 and the other two are Omicron,” Bharadwaj told ANI.

Meanwhile, a total of 109 JN.1 Covid variant cases have been reported in the country as of December 26, Health Ministry sources said on Wednesday. The World Health Organization (WHO) recently classified JN.1 as a variant of interest, distinct from its parent lineage BA.2.86. However, the global health body emphasised that the overall risk posed by JN.1 remains low based on current evidence.

Bureau Report

Be the first to comment

Leave a Reply

Your email address will not be published.


*